A March 2026 UCLA Health study published in Molecular Neurodegeneration has identified the pesticide chlorpyrifos as a specific environmental risk factor for Parkinson’s disease, finding a more than 2.5-fold increase in disease risk for individuals with long-term exposure. This isn’t another vague “pesticides are bad” headline — the study combines rigorous human epidemiology with detailed laboratory experiments to build a compelling case for a specific chemical causing specific neurological damage through identified biological mechanisms.
Chlorpyrifos: The Pesticide in Question
Chlorpyrifos is one of the most widely used organophosphate pesticides in American agriculture. For decades, it’s been applied to crops including corn, soybeans, fruit trees, and vegetables. It works by inhibiting acetylcholinesterase, an enzyme essential for nerve function in insects — but the same enzyme exists in human nervous systems, which is precisely why exposure is concerning.
The chemical has a long and contentious regulatory history. The EPA proposed banning food residue uses in 2015 but reversed course in 2017. In 2021, the EPA finally revoked all food-use tolerances, effectively banning its use on food crops. However, decades of prior use mean that millions of Americans — particularly farmworkers and residents of agricultural communities — have already accumulated significant cumulative exposure.
Understanding chlorpyrifos matters because this isn’t an abstract risk. It’s a specific chemical with identifiable exposure pathways, affected populations, and now increasingly clear mechanisms of neurological harm.
The UCLA Study: What They Found and How
The UCLA study’s strength lies in its multi-pronged approach. Rather than relying solely on epidemiological correlation, the researchers combined human population data with laboratory experiments to build a case that spans from statistical association to biological mechanism.
The human epidemiology drew from UCLA’s Parkinson’s Environment and Genes (PEG) study, comparing 829 people diagnosed with Parkinson’s to 824 healthy controls. Rather than relying on self-reported exposure — which is notoriously unreliable for events decades in the past — the researchers linked California pesticide use records dating back to 1974 with participants’ residential and workplace locations over many years. This geocoded historical exposure assessment is far more objective than asking people to remember what chemicals they were near in the 1980s.
The findings were striking: individuals with long-term residential exposure to chlorpyrifos had more than a 2.5-fold greater likelihood of developing Parkinson’s disease. For those with the highest cumulative workplace exposure, the risk rose to 2.74 times. This distinction between residential and occupational exposure is important — farmworkers experiencing direct, high-level exposure during application showed higher risk than nearby residents experiencing environmental drift.
Dr. Jeff Bronstein, professor of Neurology at UCLA Health and the study’s senior author, emphasized that this research “establishes chlorpyrifos as a specific environmental risk factor for Parkinson’s disease, not just pesticides as a general class.” That specificity is scientifically important — it narrows the focus for both research and regulatory action.
The Laboratory Evidence: How Chlorpyrifos Damages Neurons
The second component of the UCLA study moves from correlation to mechanism. The researchers used animal models to investigate how chlorpyrifos causes neurological damage at the cellular level.
Mouse models were exposed to aerosolized chlorpyrifos for 11 weeks, mimicking human inhalation exposure. These mice developed movement problems — a hallmark of Parkinson’s — and critically, they lost dopamine-producing neurons. Dopamine neuron degeneration in the substantia nigra is the primary neuropathological feature of Parkinson’s disease. The mice also showed brain inflammation and abnormal accumulation of alpha-synuclein, two other key pathological markers. Alpha-synuclein is the protein that misfolds and aggregates into Lewy bodies in Parkinson’s patients, contributing to neuronal dysfunction and death.
Zebrafish experiments revealed an even more specific mechanism: chlorpyrifos damages neurons by disrupting autophagy — the cell’s cleanup and recycling system. Autophagy is responsible for clearing out damaged proteins and organelles. When this system is disrupted, waste products including misfolded alpha-synuclein accumulate, leading to cellular stress and eventual neuronal death.
Critically, the researchers demonstrated that restoring autophagy or eliminating synuclein reduced neuronal vulnerability in zebrafish models. This doesn’t just explain how the damage occurs — it suggests potential intervention pathways for future treatment.
Understanding the Risk: Relative vs. Absolute Numbers
A “2.5-fold increase in risk” sounds dramatic, and it is significant, but understanding what it means in practice requires distinguishing between relative and absolute risk.
Relative risk tells you how much more likely an exposed group is to develop a disease compared to an unexposed group. In this case, people with long-term chlorpyrifos exposure were 2.5 times more likely to develop Parkinson’s.
Absolute risk is the actual probability of developing the disease. Parkinson’s affects approximately 1 million Americans, with about 90,000 new diagnoses annually. The lifetime risk for the general population is estimated at about 6.6%. Globally, over 8.5 million individuals had Parkinson’s in 2019.
If the baseline absolute risk over a given period is, hypothetically, 1 in 1,000 for unexposed individuals, a 2.5-fold increase means the exposed population’s risk is 2.5 in 1,000. The relative risk is significant from a clinical and public health perspective, but the absolute numbers help contextualize individual probability.
However, given Parkinson’s substantial population prevalence, even modest increases in absolute risk translate into thousands of additional cases. From a public health standpoint, identifying and reducing a specific modifiable risk factor that affects millions of people in agricultural communities is enormously valuable.
Who Is Most at Risk?
Exposure to chlorpyrifos isn’t evenly distributed across the population. Agricultural workers have the highest exposure — those who apply the chemical, enter treated fields, or work in environments where drift occurs. But risk extends well beyond the farm:
Rural residents living near agricultural operations experience chronic low-level exposure through environmental drift. The UCLA study’s finding that even residential proximity increased risk by 2.5-fold highlights that you don’t need to be handling the chemical directly.
Farmworker communities face compounded risks. Workers often lack protective equipment, may return to treated fields before recommended re-entry intervals, and frequently live in housing adjacent to treated agricultural land. Environmental justice concerns are significant — these communities are disproportionately low-income and minority populations.
Children are particularly vulnerable due to their developing nervous systems, lower body weight (meaning higher relative dose per exposure), and behaviors that increase contact (playing on floors, hand-to-mouth activity). Prior to the 2021 food-use ban, dietary exposure through pesticide residues on food was a primary pathway for the general population.
This pattern of disproportionate exposure echoes broader environmental health issues where the most vulnerable populations bear the greatest burden of chemical contamination.
The Broader Pesticide-Parkinson’s Connection
Chlorpyrifos isn’t the only pesticide linked to Parkinson’s disease. Paraquat, rotenone, and other organophosphates have also shown associations in epidemiological studies. What makes the UCLA study notable is its specificity — identifying one particular chemical and demonstrating its specific mechanism of action.
The organophosphate class of pesticides shares a common mechanism of action (acetylcholinesterase inhibition) that makes them inherently neurotoxic. While designed to target insect nervous systems, these chemicals interact with human neurobiology in ways that are increasingly well-documented.
The dopaminergic system — the network of neurons that produce and respond to dopamine — appears especially vulnerable to environmental toxicants. This system is already known to degenerate in Parkinson’s disease, and the discovery that specific pesticides can accelerate this degeneration through disrupted autophagy and alpha-synuclein accumulation provides a concrete link between environmental exposure and disease progression.
Regulatory History: A Slow Road to Action
The regulatory timeline for chlorpyrifos illustrates the challenges of translating scientific evidence into policy action:
- 1965: Chlorpyrifos first registered for use in the United States
- 2000: EPA banned most residential uses after evidence of harm to children
- 2007: EPA restricted certain agricultural uses
- 2015: EPA proposed revoking all food-use tolerances based on health concerns
- 2017: EPA reversed the proposed ban under new administration
- 2021: EPA finally revoked all food-use tolerances
- 2022: Final rule took effect, banning food-crop applications
This 56-year timeline from registration to food-use ban highlights a recurring pattern in environmental regulation: evidence of harm accumulates for decades before regulatory action catches up. During that gap, millions of people accumulate exposure that may not manifest as disease for years or decades — Parkinson’s disease typically develops decades after initial exposure begins.
California’s pesticide use reporting system, which provided the historical data enabling the UCLA study, represents one of the few comprehensive exposure tracking systems in the country. Most states lack comparable data, making it much harder to study long-term exposure effects elsewhere.
What You Can Do to Reduce Exposure
Even with the food-use ban, chlorpyrifos persists in the environment, and other neurotoxic pesticides remain in wide use. Practical steps to reduce exposure include:
For agricultural workers: Use all available protective equipment, follow re-entry intervals strictly, and shower immediately after potential exposure. Advocate for employer compliance with safety regulations.
For rural residents: Be aware of application schedules in nearby fields. Keep windows closed during application periods. Wash produce thoroughly, even if home-grown near agricultural land.
For everyone: Washing produce reduces pesticide residues, though it doesn’t eliminate them entirely. Choosing organic options for heavily treated crops (the “Dirty Dozen” list from the Environmental Working Group provides guidance) reduces dietary exposure. Supporting policy advocacy for stronger pesticide regulations addresses the systemic issue.
The Path Forward: From Research to Prevention
The UCLA study represents significant progress in understanding one specific pathway from environmental exposure to neurological disease. But translating this knowledge into effective prevention requires action across multiple fronts.
Further research needs to replicate these findings in larger, more diverse populations and establish dose-response relationships — how much exposure, over what duration, significantly increases risk? Understanding the relationship between cumulative exposure and disease onset could inform screening and early intervention.
Biomarker development could eventually enable early detection of chlorpyrifos-related neurological damage before Parkinson’s symptoms manifest. The autophagy disruption mechanism identified in the study offers a potential target for biomarker development.
Regulatory strengthening should extend beyond banning individual chemicals to addressing the class of organophosphate pesticides and developing safer alternatives for agricultural use. The health impacts of environmental contamination consistently demonstrate that prevention is far more effective than treatment.
The study’s transparency — funded by The Levine Foundation and NIH, with authors declaring no competing interests — supports confidence in its findings while acknowledging the need for continued investigation. Science advances incrementally, and this study is a substantial increment.
Frequently Asked Questions
What is chlorpyrifos and where is it used? Chlorpyrifos is an organophosphate pesticide widely used in agriculture for decades, particularly on crops like corn, soybeans, and fruit trees. The EPA revoked food-use tolerances in 2021, but legacy contamination and non-food uses may continue.
How does chlorpyrifos cause Parkinson’s disease? According to the UCLA study, chlorpyrifos disrupts autophagy — the cell’s cleanup system — leading to accumulation of misfolded alpha-synuclein protein, brain inflammation, and loss of dopamine-producing neurons. These are the hallmark pathological features of Parkinson’s disease.
Does a 2.5-fold risk mean I’ll definitely get Parkinson’s? No. A 2.5-fold increase is a relative risk measure. The absolute risk for any individual depends on baseline risk, duration and intensity of exposure, genetic factors, and other variables. Most exposed individuals will not develop Parkinson’s, but the increased probability is clinically significant.
Is chlorpyrifos still being used? Food-crop applications have been banned since 2022, but non-food agricultural uses may continue in some jurisdictions, and the chemical persists in the environment from decades of prior use.
Can anything reverse the damage from chlorpyrifos exposure? The UCLA zebrafish experiments showed that restoring autophagy or eliminating synuclein accumulation reduced neuronal vulnerability. While this suggests potential future therapeutic targets, no proven treatment currently exists for reversing chlorpyrifos-related neurological damage. Prevention of further exposure remains the primary strategy.
Am I at risk if I live near farmland? The study found increased Parkinson’s risk even with residential proximity to agricultural land, not just occupational exposure. If you live near areas where chlorpyrifos was historically or currently applied, your cumulative exposure may be elevated.